Oncology Clinical Trials in Rochester, NY

As of August 2026, 100 paid clinical trials are recruiting for Oncology in Rochester, New York. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 27, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

102 clinical trials for Oncology

·Clear filters·

Email me when a new oncology trial opens in Rochester, NY.

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

for Mantle Cell Lymphoma

Sites in Rochester, Webster +228 more locations

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 60+

Code: NCT05976763·Phase 3·Recruiting·Listed Aug 2023

Apply to this trial

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

for Acute Myeloid Leukemia

Sites in Rochester, Buffalo +204 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18 - 59

Code: NCT05554406·Phase 2·Recruiting·Listed Sep 2022

Apply to this trial

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Rochester, Buffalo +214 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06317649·Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Rochester, Buffalo +167 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18 - 59

Code: NCT05554393·Phase 2·Recruiting·Listed Sep 2022

Apply to this trial

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

for Hematopoietic and Lymphatic System Neoplasm

Sites in Rochester, Albany +189 more locations

Sponsor: Children's Oncology Group

Sex: Female·Age: Up to 39

Code: NCT06513962·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

for Anatomic Stage IV Breast Cancer AJCC v8

Sites in Rochester, Syracuse +255 more locations

Sponsor: NRG Oncology

Sex: All·Age: 18+

Code: NCT06500455·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

for Acute Myeloid Leukemia

Sites in Rochester, Buffalo +127 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06672146·Phase 2·Recruiting·Listed Nov 2024

Apply to this trial

Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

for Hodgkin Lymphoma

Sites in Rochester, The Bronx +403 more locations

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All·Age: 18+

Code: NCT06002828·Recruiting·Listed Aug 2023

Apply to this trial

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for B Acute Lymphoblastic Leukemia

Sites in Rochester, Buffalo +185 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: 365 Days - 25

Code: NCT03959085·Phase 3·Recruiting·Listed May 2019

Apply to this trial

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

for Acute Myeloid Leukemia

Sites in Rochester, Buffalo +167 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 21

Code: NCT04293562·Phase 3·Recruiting·Listed Mar 2020

Apply to this trial

Project: Every Child for Younger Patients With Cancer

for Adrenal Gland Pheochromocytoma

Sites in Rochester, Buffalo +225 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 25

Code: NCT02402244·Recruiting·Listed Mar 2015

Apply to this trial

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

for Ganglioneuroblastoma, Nodular

Sites in Rochester, Buffalo +152 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: Up to 30

Code: NCT06172296·Phase 3·Recruiting·Listed Dec 2023

Apply to this trial

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

for Prostate Adenocarcinoma

Sites in Rochester, Webster +397 more locations

Sponsor: NRG Oncology

Sex: Male·Age: 18+

Code: NCT05946213·Phase 3·Recruiting·Listed Jul 2023

Apply to this trial

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for Ganglioneuroblastoma

Sites in Rochester, Buffalo +141 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: 365 Days - 30

Code: NCT03126916·Phase 3·Recruiting·Listed Apr 2017

Apply to this trial

Pancreatic Cancer Early Detection Consortium

for Pancreas Cancer

Sites in Rochester, White Plains +40 more locations

Sponsor: Arbor Research Collaborative for Health

Sex: All·Age: 18 - 90·Accepts healthy volunteers

Code: NCT04970056·Recruiting·Listed Jul 2021

Apply to this trial

Increasing Lung Cancer Screening Uptake Among Emergency Department Patients

for Screening Compliance

1 location in Rochester

Sponsor: University of Rochester

Sex: All·Age: 50 - 80·Accepts healthy volunteers

Code: NCT07287085·Recruiting·Listed Dec 2025

Apply to this trial

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

for Non-small Cell Lung Cancer

Sites in Rochester, Syracuse +69 more locations

Sponsor: Canadian Cancer Trials Group

Sex: All·Age: 18+

Code: NCT06686771·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

for Hematologic Malignancies

Sites in Rochester, Buffalo +111 more locations

Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All·Age: All ages

Code: NCT01351545·Recruiting·Listed May 2011

Apply to this trial

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

for Rectal Cancer

Sites in Rochester, Webster +101 more locations

Sponsor: Canadian Cancer Trials Group

Sex: All·Age: 18+

Code: NCT06205485·Phase 3·Recruiting·Listed Jan 2024

Apply to this trial

Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

for Rectal Adenocarcinoma

Sites in Rochester +2 more locations

Sponsor: University of Colorado, Denver

Sex: All·Age: 18 - 100

Code: NCT07292298·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Measuring Surgical Recovery After Radical Cystectomy

for Bladder Cancer

Sites in Rochester, Mineola +8 more locations

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT03193970·Recruiting·Listed Jun 2017

Apply to this trial

Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy

for Lung Cancer

Sites in Rochester +2 more locations

Sponsor: Bo Lu

Sex: All·Age: 18+

Code: NCT06410300·Recruiting·Listed May 2024

Apply to this trial

A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer

for Prostate Cancer

1 location in Rochester

Sponsor: University of Rochester

Sex: Male·Age: 18 - 70

Code: NCT05530655·EARLY_Phase 1·Recruiting·Listed Sep 2022

Apply to this trial

Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer

for Lung Cancer

1 location in Rochester

Sponsor: University of Rochester

Sex: All·Age: 18+

Code: NCT03706027·Recruiting·Listed Oct 2018

Apply to this trial

A Randomized Trial of a Mobile Health Exercise Intervention for Older Adults With Myeloid Neoplasms

for Cancer

1 location in Rochester

Sponsor: University of Rochester

Sex: All·Age: 60+

Code: NCT04981821·Recruiting·Listed Jul 2021

Apply to this trial

Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy

for Lung Non-Small Cell Carcinoma

Sites in Rochester +2 more locations

Sponsor: City of Hope Medical Center

Sex: All·Age: 60+·Accepts healthy volunteers

Code: NCT06139627·Recruiting·Listed Nov 2023

Apply to this trial

A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers

for Oncology

Sites in Rochester +3 more locations

Sponsor: University of Rochester

Sex: All·Age: 60+

Code: NCT06697600·Recruiting·Listed Nov 2024

Apply to this trial

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

for Breast Neoplasms

Sites in Rochester, Buffalo +31 more locations

Sponsor: QuantumLeap Healthcare Collaborative

Sex: All·Age: 18+

Code: NCT01042379·Phase 2·Recruiting·Listed Jan 2010

Apply to this trial

Epcoritamab and Rituximab for First-line Follicular Lymphoma

for Follicular Lymphoma

Drug: Epcoritamab

Sites in Rochester, New York +4 more locations

Sponsor: Reid Merryman, MD

Sex: All·Age: 18+

Code: NCT05783609·Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2

for Non-small Cell Lung Cancer

2 locations in Rochester

Sponsor: University of Rochester

Sex: All·Age: 18+

Code: NCT04297605·Phase 1·Recruiting·Listed Mar 2020

Apply to this trial

Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

for Acute Myeloid Leukemia

1 location in Rochester

Sponsor: Omar Aljitawi

Sex: All·Age: 18 - 75

Code: NCT03964506·EARLY_Phase 1·Recruiting·Listed May 2019

Apply to this trial

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

for Hearing Loss

Sites in Rochester +4 more locations

Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD)

Sex: All·Age: 18 - 100

Code: NCT04915183·Phase 2·Recruiting·Listed Jun 2021

Apply to this trial

Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women

for Ovarian Cancer

Sites in Rochester +9 more locations

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 50 - 74·Accepts healthy volunteers

Code: NCT00539162·Recruiting·Listed Oct 2007

Apply to this trial

Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)

for Multiple Myeloma

Drug: Teclistamab

Sites in Rochester +1 more location

Sponsor: Noffar Bar

Sex: All·Age: 18+

Code: NCT06993675·Phase 2·Recruiting·Listed May 2025

Apply to this trial

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

for Diffuse Large B-Cell Lymphoma

Sites in Rochester, Webster +81 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT05633615·Phase 2·Recruiting·Listed Dec 2022

Apply to this trial

Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI

for Cancer Related Cognitive Difficulties

1 location in Rochester

Sponsor: University of Rochester

Sex: Female·Age: 21+·Accepts healthy volunteers

Code: NCT03137095·Recruiting·Listed May 2017

Apply to this trial

SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers

for Breast Cancer

Sites in Rochester +10 more locations

Sponsor: Beth Israel Deaconess Medical Center

Sex: All·Age: 18+

Code: NCT06896474·Recruiting·Listed Mar 2025

Apply to this trial

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

for Metastatic Clear Cell Renal Cell Carcinoma

Sites in Rochester, Buffalo +338 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT04510597·Phase 3·Recruiting·Listed Aug 2020

Apply to this trial

Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

for Lymphoma

Sites in Rochester, Webster +42 more locations

Sponsor: University of Rochester

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT05006482·Phase 3·Recruiting·Listed Aug 2021

Apply to this trial

Exercise and Cognitive Rehab in Older Cancer Survivors

for Cancer

1 location in Rochester

Sponsor: University of Rochester

Sex: All·Age: 60+

Code: NCT05388214·Recruiting·Listed May 2022

Apply to this trial

Conditions in Oncology (Rochester, NY)

Breast cancer· 15 Acute myeloid leukemia (AML)· 12 Non-small cell lung cancer (NSCLC)· 8 Cancer (any)· 8 Pancreatic cancer· 7 Prostate cancer· 7 Solid tumor· 7 Ovarian cancer· 6 Myelodysplastic syndromes (MDS)· 6 Non-Hodgkin lymphoma· 6 Lung cancer· 5 Multiple myeloma· 4 Leukemia (other)· 4 Metastatic breast cancer· 3 Bladder cancer· 3 Kidney cancer· 3 Glioma· 3 Chronic lymphocytic leukemia (CLL)· 3 Diffuse large B-cell lymphoma (DLBCL)· 3 Follicular lymphoma· 3 Hematologic malignancy· 3 HER2-positive breast cancer· 2 Rectal cancer· 2 Esophageal cancer· 2 Myelofibrosis· 2 Hodgkin lymphoma· 2 Small lymphocytic lymphoma· 2 Head and neck cancer· 2 Rhabdomyosarcoma· 2 Neuroblastoma· 2 Triple-negative breast cancer· 1 HER2-negative breast cancer· 1 Metastatic colorectal cancer· 1 Liver cancer· 1 Gastrointestinal cancer· 1 Glioblastoma· 1 Chronic myelomonocytic leukemia· 1 Myeloproliferative neoplasm· 1 Mantle cell lymphoma· 1 Marginal zone lymphoma· 1 Melanoma· 1 Sarcoma· 1 Osteosarcoma· 1